Prado JG - Search Results

1

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2.

Barreiro A, Prenafeta A, Bech-Sabat G, Roca M, Perozo Mur E, March R, González-González L, Madrenas L, Corominas J, Fernández A, Moros A, Cañete M, Molas M, Pentinat-Pelegrin T, Panosa C, Moreno A, Puigvert Molas E, Pol Vilarrassa E, Palmada J, Garriga C, Prat Cabañas T, Iglesias-Fernández J, Vergara-Alert J, Lorca-Oró C, Roca N, Fernández-Bastit L, Rodon J, Pérez M, Segalés J, Pradenas E, Marfil S, Trinité B, Ortiz R, Clotet B, Blanco J, Díaz Pedroza J, Ampudia Carrasco R, Rosales Salgado Y, Loubat-Casanovas J, Capdevila Larripa S, Prado JG, Barretina J, Sisteré-Oró M, Cebollada Rica P, Meyerhans A, Ferrer L. Barreiro A, et al. Among authors: prado jg. iScience. 2023 Mar 17;26(3):106126. doi: 10.1016/j.isci.2023.106126. Epub 2023 Feb 2. iScience. 2023. PMID: 36748086 Free PMC article.

2

Selection of drug-resistant HIV-1 mutants in response to repeated structured treatment interruptions.

Martinez-Picado J, Morales-Lopetegi K, Wrin T, Prado JG, Frost SD, Petropoulos CJ, Clotet B, Ruiz L. Martinez-Picado J, et al. Among authors: prado jg. AIDS. 2002 Apr 12;16(6):895-9. doi: 10.1097/00002030-200204120-00009. AIDS. 2002. PMID: 11919491

3

Lack of longitudinal intrapatient correlation between p24 antigenemia and levels of human immunodeficiency virus (HIV) type 1 RNA in patients with chronic hiv infection during structured treatment interruptions.

Prado JG, Shintani A, Bofill M, Clotet B, Ruiz L, Martinez-Picado J. Prado JG, et al. J Clin Microbiol. 2004 Apr;42(4):1620-5. doi: 10.1128/JCM.42.4.1620-1625.2004. J Clin Microbiol. 2004. PMID: 15071015 Free PMC article. Clinical Trial.

4

Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215.

Prado JG, Franco S, Matamoros T, Ruiz L, Clotet B, Menéndez-Arias L, Martínez MA, Martinez-Picado J. Prado JG, et al. Virology. 2004 Aug 15;326(1):103-12. doi: 10.1016/j.virol.2004.06.006. Virology. 2004. PMID: 15262499 Free article.

5

HIV type 1 fitness evolution in antiretroviral-experienced patients with sustained CD4+ T cell counts but persistent virologic failure.

Prado JG, Parkin NT, Clotet B, Ruiz L, Martinez-Picado J. Prado JG, et al. Clin Infect Dis. 2005 Sep 1;41(5):729-37. doi: 10.1086/432619. Epub 2005 Jul 22. Clin Infect Dis. 2005. PMID: 16080097

6

Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells.

Izquierdo-Useros N, Esteban O, Rodriguez-Plata MT, Erkizia I, Prado JG, Blanco J, García-Parajo MF, Martinez-Picado J. Izquierdo-Useros N, et al. Among authors: prado jg. Traffic. 2011 Dec;12(12):1702-13. doi: 10.1111/j.1600-0854.2011.01281.x. Epub 2011 Oct 10. Traffic. 2011. PMID: 21917091 Free article.

7

In-depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection.

Dalmau J, Codoñer FM, Erkizia I, Pino M, Pou C, Paredes R, Clotet B, Martinez-Picado J, Prado JG. Dalmau J, et al. Among authors: prado jg. PLoS One. 2012;7(2):e32714. doi: 10.1371/journal.pone.0032714. Epub 2012 Feb 29. PLoS One. 2012. PMID: 22393441 Free PMC article.

8

Novel two-round phenotypic assay for protease inhibitor susceptibility testing of recombinant and primary HIV-1 isolates.

Puertas MC, Buzón MJ, Ballestero M, Van Den Eede P, Clotet B, Prado JG, Martinez-Picado J. Puertas MC, et al. Among authors: prado jg. J Clin Microbiol. 2012 Dec;50(12):3909-16. doi: 10.1128/JCM.01636-12. Epub 2012 Sep 26. J Clin Microbiol. 2012. PMID: 23015664 Free PMC article.

9

Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection: The Phase 2 DURVAST Study.

Gonzalez-Cao M, Morán T, Dalmau J, Garcia-Corbacho J, Bracht JWP, Bernabe R, Juan O, de Castro J, Blanco R, Drozdowskyj A, Argilaguet J, Meyerhans A, Blanco J, Prado JG, Carrillo J, Clotet B, Massuti B, Provencio M, Molina-Vila MA, Mayo de Las Casa C, Garzon M, Cao P, Huang CY, Martinez-Picado J, Rosell R. Gonzalez-Cao M, et al. Among authors: prado jg. JAMA Oncol. 2020 Jul 1;6(7):1063-1067. doi: 10.1001/jamaoncol.2020.0465. JAMA Oncol. 2020. PMID: 32271353 Free PMC article. Clinical Trial.

10

HIV-1 Gag mutations alone are sufficient to reduce darunavir susceptibility during virological failure to boosted PI therapy.

Blanch-Lombarte O, Santos JR, Peña R, Jiménez-Moyano E, Clotet B, Paredes R, Prado JG. Blanch-Lombarte O, et al. Among authors: prado jg. J Antimicrob Chemother. 2020 Sep 1;75(9):2535-2546. doi: 10.1093/jac/dkaa228. J Antimicrob Chemother. 2020. PMID: 32556165 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

69 results

Search Page